These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

822 related items for PubMed ID: 11223671

  • 1. Early detection of prostate cancer in Germany: a study using digital rectal examination and 4.0 ng/ml prostate-specific antigen as cutoff.
    Luboldt HJ, Bex A, Swoboda A, Hüsing J, Rübben H, Early Detection Project Group of the German Urological Association.
    Eur Urol; 2001 Feb; 39(2):131-7. PubMed ID: 11223671
    [Abstract] [Full Text] [Related]

  • 2. Clinical usefulness of free PSA in early detection of prostate cancer.
    Luboldt HJ, Swoboda A, Börgermann C, Fornara P, Rübben H, Early Detection Project Group of the German Society of Urology.
    Onkologie; 2001 Feb; 24(1):33-7. PubMed ID: 11441278
    [Abstract] [Full Text] [Related]

  • 3. Efficiency of prostate-specific antigen and digital rectal examination in screening, using 4.0 ng/ml and age-specific reference range as a cutoff for abnormal values.
    Crawford ED, Leewansangtong S, Goktas S, Holthaus K, Baier M.
    Prostate; 1999 Mar 01; 38(4):296-302. PubMed ID: 10075009
    [Abstract] [Full Text] [Related]

  • 4. Early diagnosis of prostate cancer in the Western Cape.
    Heyns CF, Naudé AM, Visser AJ, Marais DC, Stopforth HB, Nyarko JK, Stellmacher GA.
    S Afr Med J; 2001 Aug 01; 91(8):679-84. PubMed ID: 11584784
    [Abstract] [Full Text] [Related]

  • 5. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.
    Uzzo RG, Pinover WH, Horwitz EM, Parlanti A, Mazzoni S, Raysor S, Mirchandani I, Greenberg RE, Pollack A, Hanks GE, Watkins-Bruner D.
    Urology; 2003 Apr 01; 61(4):754-9. PubMed ID: 12670560
    [Abstract] [Full Text] [Related]

  • 6. Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination.
    Richie JP, Catalona WJ, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, deKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, Waters WB, MacFarlane MT, Southwick PC.
    Urology; 1993 Oct 01; 42(4):365-74. PubMed ID: 7692657
    [Abstract] [Full Text] [Related]

  • 7. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
    Mäkinen T, Tammela TL, Hakama M, Stenman UH, Rannikko S, Aro J, Juusela H, Määttänen L, Auvinen A.
    J Urol; 2001 Oct 01; 166(4):1339-42. PubMed ID: 11547069
    [Abstract] [Full Text] [Related]

  • 8. Multiple vesico-urethral biopsies following radical prostatectomy: the predictive roles of TRUS, DRE, PSA and the pathological stage.
    Scattoni V, Roscigno M, Raber M, Montorsi F, Da Pozzo L, Guazzoni G, Freschi M, Rigatti P.
    Eur Urol; 2003 Oct 01; 44(4):407-14. PubMed ID: 14499673
    [Abstract] [Full Text] [Related]

  • 9. Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examination.
    Schröder FH, Roobol-Bouts M, Vis AN, van der Kwast T, Kranse R.
    Urology; 2001 Jan 01; 57(1):83-90. PubMed ID: 11164149
    [Abstract] [Full Text] [Related]

  • 10. Serum prostate-specific antigen and digital rectal examination for early detection of prostate cancer in a national community-based program. The Prostate Cancer Education Council.
    Crawford ED, DeAntoni EP, Etzioni R, Schaefer VC, Olson RM, Ross CA.
    Urology; 1996 Jun 01; 47(6):863-9. PubMed ID: 8677578
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer.
    Candas B, Cusan L, Gomez JL, Diamond P, Suburu RE, Lévesque J, Brousseau G, Bélanger A, Labrie F.
    Prostate; 2000 Sep 15; 45(1):19-35. PubMed ID: 10960839
    [Abstract] [Full Text] [Related]

  • 12. Utility of free/total prostate specific antigen (f/t PSA) ratio in diagnosis of prostate carcinoma.
    Thakur V, Singh PP, Talwar M, Mukherjee U.
    Dis Markers; 2000 Sep 15; 19(6):287-92. PubMed ID: 15258330
    [Abstract] [Full Text] [Related]

  • 13. Prostate cancer detection at low prostate specific antigen.
    Schröder FH, van der Cruijsen-Koeter I, de Koning HJ, Vis AN, Hoedemaeker RF, Kranse R.
    J Urol; 2000 Mar 15; 163(3):806-12. PubMed ID: 10687982
    [Abstract] [Full Text] [Related]

  • 14. The risks of prostate cancer detection by transrectal ultrasound guide biopsy in Thai men with abnormal prostatic-specific antigen or abnormal digital rectal examination.
    Leewansangtong S, Tantiwong A, Ratanarapee S, Nualyong C, Soontrapa S.
    J Med Assoc Thai; 2000 Dec 15; 83(12):1519-24. PubMed ID: 11253893
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
    Schröder FH, van der Maas P, Beemsterboer P, Kruger AB, Hoedemaeker R, Rietbergen J, Kranse R.
    J Natl Cancer Inst; 1998 Dec 02; 90(23):1817-23. PubMed ID: 9839522
    [Abstract] [Full Text] [Related]

  • 16. Determination of the percentage of free prostate-specific antigen helps to avoid unnecessary biopsies in men with normal rectal examinations and total prostate-specific antigen of 4-10 ng/ml.
    Martínez-Piñeiro L, Tabernero A, Contreras T, Madero R, Lozano D, López-Tello J, Alonso-Dorrego JM, Picazo ML, González Gancedo P, Martínez-Piñeiro JA, de La Peña JJ.
    Eur Urol; 2000 Mar 02; 37(3):289-96. PubMed ID: 10720854
    [Abstract] [Full Text] [Related]

  • 17. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
    Faria EF, Carvalhal GF, dos Reis RB, Tobias-Machado M, Vieira RA, Reis LO, Nogueira L, Machado RD, Freitas CH, Magnabosco WJ, Mauad EC, Carvalho AL.
    BJU Int; 2012 Dec 02; 110(11 Pt B):E653-7. PubMed ID: 22892057
    [Abstract] [Full Text] [Related]

  • 18. Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model.
    Catalona WJ, Partin AW, Finlay JA, Chan DW, Rittenhouse HG, Wolfert RL, Woodrum DL.
    Urology; 1999 Aug 02; 54(2):220-4. PubMed ID: 10443714
    [Abstract] [Full Text] [Related]

  • 19. [Yield of ultrasonography-guided transrectal biopsy in the diagnosis of carcinoma of the prostate].
    Fernández González I, Ruiz Rubio JL, Llorente Abarca C, Aramburu González JA, Montes Díaz MJ, Herrero Payo A, Sánchez Sánchez E, Berenguer Sánchez A.
    Arch Esp Urol; 1995 Aug 02; 48(6):587-94. PubMed ID: 7544968
    [Abstract] [Full Text] [Related]

  • 20. The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density.
    Bangma CH, Kranse R, Blijenberg BG, Schröder FH.
    Urology; 1995 Dec 02; 46(6):779-84. PubMed ID: 7502415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.